Patent · US Active

Pharmaceutical semi-solid composition of isotretinoin

US9089534B2 · kind B2 · utility

4Cited by

11References

35Claims

0Family size

Assignee

GALEPHAR PHARMACEUTICAL RESEARCH, INC. · US

Inventors

Francis Vanderbist · Sint-Genesius-Rode, BE
Cecile Servais · Malonne, BE
Philippe Baudier · Waterloo, BE

Key dates

Filing date	Dec 13, 2012
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Dec 13, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/1075
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.